Literature DB >> 21543435

Coronary bypass surgery: protective effects of insulin or of prevention of hyperglycemia, or both?

Greet Van den Berghe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21543435     DOI： 10.1210/jc.2011-0683

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  4 in total

1.  Critical care management of the adult patient with congenital heart disease: focus on postoperative management and outcomes.

Authors:  Nathalie Roy
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-02

2.  Oleanolic acid: a novel cardioprotective agent that blunts hyperglycemia-induced contractile dysfunction.

Authors:  Rudo F Mapanga; Uthra Rajamani; Nonkululeko Dlamini; Makhosazane Zungu-Edmondson; Roisin Kelly-Laubscher; Mohammed Shafiullah; Athiq Wahab; Mohamed Y Hasan; Mohamed A Fahim; Philippe Rondeau; Emmanuel Bourdon; M Faadiel Essop
Journal:  PLoS One       Date:  2012-10-16       Impact factor: 3.240

3.  Major themes for 2011 in cardiovascular anesthesia and intensive care.

Authors:  H Riha; P Patel; E Valentine; B Lane; J G T Augoustides
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2012

4.  Factors associated with hyperglycemia and low insulin levels in children undergoing cardiac surgery with cardiopulmonary bypass who received a single high dose of methylprednisolone.

Authors:  Ronaldo Arkader; Luiz Marcelo Malbouisson; Gilda Maria Barbaro Del Negro; Lidia Yamamoto; Thelma Suely Okay
Journal:  Clinics (Sao Paulo)       Date:  2013-01       Impact factor: 2.365
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.